Research Article
N6-Methyladenosine (m6A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma
Table 2
Characteristics of LUSC patients in training, testing, and entire sets from TCGA database.
| | Characteristics | Type | Total | Test | Train | value |
| | Age | ≤65 | 189 (38.18%) | 63 (42.86%) | 126 (36.21%) | 0.1632 | | >65 | 300 (60.61%) | 81 (55.1%) | 219 (62.93%) | | Unknown | 6 (1.21%) | 3 (2.04%) | 3 (0.86%) |
| | Gender | Female | 129 (26.06%) | 40 (27.21%) | 89 (25.57%) | 0.7896 | | Male | 366 (73.94%) | 107 (72.79%) | 259 (74.43%) |
| | Stage | Stage I | 242 (48.89%) | 68 (46.26%) | 174 (50%) | 0.5604 | | Stage II | 159 (32.12%) | 53 (36.05%) | 106 (30.46%) | | Stage III | 83 (16.77%) | 21 (14.29%) | 62 (17.82%) | | Stage IV | 7 (1.41%) | 2 (1.36%) | 5 (1.44%) | | Unknown | 4 (0.81%) | 3 (2.04%) | 1 (0.29%) |
| | T | T1 | 114 (23.03%) | 30 (20.41%) | 84 (24.14%) | 0.718 | | T2 | 288 (58.18%) | 91 (61.9%) | 197 (56.61%) | | T3 | 70 (14.14%) | 19 (12.93%) | 51 (14.66%) | | T4 | 23 (4.65%) | 7 (4.76%) | 16 (4.6%) |
| | M | M0 | 407 (82.22%) | 117 (79.59%) | 290 (83.33%) | 1 | | M1 | 7 (1.41%) | 2 (1.36%) | 5 (1.44%) | | Unknown | 81 (16.36%) | 28 (19.05%) | 53 (15.23%) |
| | N | N0 | 316 (63.84%) | 98 (66.67%) | 218 (62.64%) | 0.4745 | | N1 | 128 (25.86%) | 31 (21.09%) | 97 (27.87%) | | N2 | 40 (8.08%) | 13 (8.84%) | 27 (7.76%) | | N3 | 5 (1.01%) | 2 (1.36%) | 3 (0.86%) | | Unknown | 6 (1.21%) | 3 (2.04%) | 3 (0.86%) |
|
|
